BR112017013255A2 - emplastro em gel - Google Patents

emplastro em gel

Info

Publication number
BR112017013255A2
BR112017013255A2 BR112017013255-9A BR112017013255A BR112017013255A2 BR 112017013255 A2 BR112017013255 A2 BR 112017013255A2 BR 112017013255 A BR112017013255 A BR 112017013255A BR 112017013255 A2 BR112017013255 A2 BR 112017013255A2
Authority
BR
Brazil
Prior art keywords
fatty acid
acid ester
surfactant
plaster layer
gel plaster
Prior art date
Application number
BR112017013255-9A
Other languages
English (en)
Japanese (ja)
Other versions
BR112017013255B1 (pt
Inventor
Tsurushima Keiichiro
Kose Yasuhisa
Yoshinaga Takaaki
Original Assignee
Hisamitsu Pharmaceutical Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co., Inc. filed Critical Hisamitsu Pharmaceutical Co., Inc.
Publication of BR112017013255A2 publication Critical patent/BR112017013255A2/pt
Publication of BR112017013255B1 publication Critical patent/BR112017013255B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)

Abstract

a presente invenção refere-se a um cataplasma que é sequencialmente provido com um tecido de base, uma camada de emplastro e um fitilho de abertura nesta ordem e onde: o camada de emplastro contém uma substância biologicamente ativa, um polímero (met)acrílico, água, um tensoativo e um poli(acrilato de metila/acrilato de 2-etilexila); e o tensoativo contém um éster de ácido graxo de polietileno glicol ou um éster de ácido graxo de polioxietileno sorbitano.
BR112017013255-9A 2014-12-22 2015-12-14 Cataplasma BR112017013255B1 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2014-258879 2014-12-22
JP2014258879 2014-12-22
JP2015-178693 2015-09-10
JP2015178693 2015-09-10
PCT/JP2015/084971 WO2016104227A1 (ja) 2014-12-22 2015-12-14 パップ剤

Publications (2)

Publication Number Publication Date
BR112017013255A2 true BR112017013255A2 (pt) 2018-01-09
BR112017013255B1 BR112017013255B1 (pt) 2022-08-09

Family

ID=56128203

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017013255-9A BR112017013255B1 (pt) 2014-12-22 2015-12-14 Cataplasma

Country Status (10)

Country Link
US (2) US20170348248A1 (pt)
EP (1) EP3238717B1 (pt)
JP (1) JP6469136B2 (pt)
KR (1) KR102094586B1 (pt)
CN (1) CN107106511B (pt)
BR (1) BR112017013255B1 (pt)
ES (1) ES2753584T3 (pt)
HK (2) HK1243330A1 (pt)
TW (1) TWI672154B (pt)
WO (1) WO2016104227A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6469136B2 (ja) * 2014-12-22 2019-02-13 久光製薬株式会社 パップ剤
KR101913055B1 (ko) * 2015-02-24 2018-10-29 히사미쓰 세이야꾸 가부시키가이샤 파프제
EP3586833B1 (en) * 2017-02-21 2021-07-07 Hisamitsu Pharmaceutical Co., Inc. Transdermal patch base and transdermal patch using same
EP3760231A4 (en) * 2018-02-27 2022-01-19 Hisamitsu Pharmaceutical Co., Inc. EMULSIFIED GEL COMPOSITION
CN112689505B (zh) 2018-09-26 2024-09-10 日绊株式会社 含水贴剂
JP2020066592A (ja) * 2018-10-24 2020-04-30 帝國製薬株式会社 水性貼付剤
US11903915B2 (en) 2019-02-14 2024-02-20 Hisamitsu Pharmaceutical Co., Inc. Poultice
WO2021193874A1 (ja) 2020-03-27 2021-09-30 ニチバン株式会社 貼付剤

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69010076T2 (de) * 1989-05-25 1994-12-08 Takeda Chemical Industries Ltd Transdermales therapeutisches Mittel.
JP2849937B2 (ja) 1990-04-18 1999-01-27 日東電工株式会社 医療用貼付剤
JP3782834B2 (ja) 1994-10-26 2006-06-07 株式会社トクホン 鎮痛抗炎症貼付剤
EP0879597A4 (en) * 1996-02-07 2001-01-31 Tsumura & Co TRANSPARENT AQUEOUS SOLUTION OF DICLOFENAC SODIUM, MEDICINAL COMPOSITIONS, AND USES
JPH09208462A (ja) * 1996-02-07 1997-08-12 Tsumura & Co 自己粘着型パップ剤
DE60043017D1 (de) * 1999-08-20 2009-11-05 Takeda Pharmaceutical Zusammensetzung für perkutane Absorption mit einem melantoninrezeptor-agonistisch wirkendem Wirkstoff
BR0110799A (pt) * 2000-05-15 2003-02-11 Hisamitsu Pharmaceutical Co Máscaras do tipo folha
JP4707221B2 (ja) 2000-09-29 2011-06-22 株式会社ダイゾー エアゾール組成物
JP4799783B2 (ja) 2001-09-27 2011-10-26 帝國製薬株式会社 伸縮性外用貼付剤
JP2005526879A (ja) * 2002-03-11 2005-09-08 ファースト ウォーター リミテッド 吸収性ハイドロゲル
JP4073231B2 (ja) * 2002-03-28 2008-04-09 久光製薬株式会社 シ−ト状貼付剤
US7166235B2 (en) * 2002-05-09 2007-01-23 The Procter & Gamble Company Compositions comprising anionic functionalized polyorganosiloxanes for hydrophobically modifying surfaces and enhancing delivery of active agents to surfaces treated therewith
JP4256125B2 (ja) 2002-08-05 2009-04-22 ロート製薬株式会社 外用組成物
JP4213432B2 (ja) * 2002-08-28 2009-01-21 久光製薬株式会社 貼付剤
TW200418487A (en) * 2002-09-17 2004-10-01 Nippon Boehringer Ingelheim Co Pharmaceutical composition for topical delivery of meloxicam comprising an amine or amine as penetration enhancer.
JP4398158B2 (ja) * 2002-10-03 2010-01-13 久光製薬株式会社 貼付剤
TW200427470A (en) * 2002-10-30 2004-12-16 Showa Denko Kk Adhesive composition for dermal patch and production process thereof
EP1568365B1 (en) * 2002-11-27 2018-04-11 Hisamitsu Pharmaceutical Co. Inc. Warm poultice
GB0229087D0 (en) * 2002-12-12 2003-01-15 First Water Ltd Absorbent hydrogel compositions
JP4318467B2 (ja) 2003-02-24 2009-08-26 大協薬品工業株式会社 低皮膚刺激性硬膏剤及びその製造法
TWI337086B (en) 2003-09-03 2011-02-11 Hisamitsu Pharmaceutical Co Transdermal formulation containing nonsteroidal antiinflammatory drug
WO2005077364A1 (ja) * 2004-02-18 2005-08-25 Yamanouchi Pharmaceutical Co., Ltd. ソリフェナシンの経皮投与製剤およびその経皮透過改善方法
JP4559753B2 (ja) 2004-02-27 2010-10-13 久光製薬株式会社 皮膚外用クリーム剤
TWI412570B (zh) * 2004-04-27 2013-10-21 Showa Denko Kk Adhesive for patch and method for producing the same
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
GB0425799D0 (en) * 2004-11-23 2004-12-22 First Water Ltd Absorbent hydrogel composites
WO2006090782A1 (ja) * 2005-02-23 2006-08-31 Saitama Daiichi Pharmaceutical Co., Ltd. 含水系外用貼付剤用組成物及びこの組成物を用いた貼付剤
WO2006118173A1 (ja) * 2005-04-28 2006-11-09 Ono Pharmaceutical Co., Ltd. 経皮吸収製剤
EP2123296B1 (en) * 2007-01-31 2019-05-22 Hisamitsu Pharmaceutical Co., Inc. Adjuvant for transdermal or transmucosal administration and pharmaceutical preparation containing the same
US9511016B2 (en) * 2007-06-12 2016-12-06 Epicentrx, Inc. Topical composition for treating pain
JP2011121866A (ja) * 2008-03-31 2011-06-23 Rohto Pharmaceutical Co Ltd 皮膚外用組成物
JP5319950B2 (ja) * 2008-04-08 2013-10-16 帝國製薬株式会社 塩酸ブテナフィン含有水性貼付剤
JP5346669B2 (ja) * 2008-04-23 2013-11-20 興和株式会社 皮膚外用貼付剤
KR101490708B1 (ko) * 2008-06-20 2015-02-09 (주)아모레퍼시픽 록소프로펜 또는 그의 염을 포함하는 경피 흡수용 조성물및 이를 포함하는 경피 투여 첩부제
JP5544935B2 (ja) 2010-03-05 2014-07-09 ライオン株式会社 貼付剤
JP5622410B2 (ja) * 2010-03-12 2014-11-12 帝國製薬株式会社 ケトプロフェン含有水性貼付剤
WO2012057220A1 (ja) * 2010-10-28 2012-05-03 久光製薬株式会社 経皮吸収型製剤
CN103313732B (zh) * 2010-11-12 2017-07-25 日产化学工业株式会社 含有脂质肽型胶凝剂和高分子化合物的凝胶片
CN103501779B (zh) * 2011-01-24 2016-08-10 尼普洛外用药品株式会社 含水性贴附剂
JP2012158572A (ja) * 2011-02-02 2012-08-23 Nitto Denko Corp 貼付製剤の製造方法
JP5818709B2 (ja) * 2011-02-02 2015-11-18 日東電工株式会社 貼付製剤
JP5280472B2 (ja) 2011-03-02 2013-09-04 第一三共株式会社 外用消炎鎮痛剤組成物
ES2705028T3 (es) * 2011-07-21 2019-03-21 Teikoku Seiyaku Kk Yeso a base de agua
SG11201400167VA (en) * 2011-08-25 2014-06-27 Nipro Patch Co Ltd Hydrous adhesive skin patch
KR101890011B1 (ko) * 2011-12-07 2018-08-20 히사미쓰 세이야꾸 가부시키가이샤 첩부제
JP5921779B2 (ja) * 2013-08-23 2016-05-24 久光製薬株式会社 パップ剤及びその製造方法
JP6469136B2 (ja) * 2014-12-22 2019-02-13 久光製薬株式会社 パップ剤

Also Published As

Publication number Publication date
BR112017013255B1 (pt) 2022-08-09
TW201628604A (zh) 2016-08-16
CN107106511B (zh) 2020-12-08
WO2016104227A1 (ja) 2016-06-30
EP3238717A4 (en) 2018-07-25
JP6469136B2 (ja) 2019-02-13
ES2753584T3 (es) 2020-04-13
EP3238717A1 (en) 2017-11-01
HK1243330A1 (zh) 2018-07-13
CN107106511A (zh) 2017-08-29
JPWO2016104227A1 (ja) 2017-09-28
KR20170097689A (ko) 2017-08-28
US20160175262A1 (en) 2016-06-23
TWI672154B (zh) 2019-09-21
EP3238717B1 (en) 2019-08-28
HK1245093A1 (zh) 2018-08-24
US20170348248A1 (en) 2017-12-07
KR102094586B1 (ko) 2020-03-27
US10123977B2 (en) 2018-11-13

Similar Documents

Publication Publication Date Title
BR112017013255A2 (pt) emplastro em gel
CR20190350A (es) INHIBIDORES DE TGFß1 ISOFORMA-ESPECÍFICOS CONTEXTO-PERMISIVOS Y USO DE LOS MISMOS
ZA202208792B (en) Methods of treating and preventing graft versus host disease
MA42447A (fr) Anticorps anti-pd-1, anticorps anti-pd-1 activables, et leurs procédés d'utilisation
BR112017005378A2 (pt) composições que compreendem células recombinantes de bacillus e um outro agente de controle biológico.
BR112015019440A8 (pt) curativo regulável, kit, uso e método para fortalecimento da pele
MX2019013171A (es) Formulaciones muco-adhesivas de liberacion controlada de levodopa y/o esteres de levodopa y sus usos.
ECSP14014544A (es) Compuestos terapéuticamente activos y sus métodos de uso
BR112017005509A2 (pt) composições que compreendem células recombinantes de bacillus e um outro agente de controle biológico.
CL2013000304A1 (es) Compuestos derivados de 2-arilamino-bencimidazoles inhibidores de prostaglandina e2 (mpges-1); composicion farmaceutica que los comprende; compuestos intermediarios; uso en el tratamiento de enfermedades inflamatorias y/o afecciones asociadas, en particular el dolor.
BR112015023760A2 (pt) compostos e composições terapêuticas
BR112015021858A2 (pt) curativo antimicrobiano combinado para cobertura de cateter
CL2008001123A1 (es) Compuestos derivados de acido lipoico; formulacion farmaceutica que lo comprende; y uso en el tratamiento del cancer.
BR112015023207A2 (pt) uso de c1-inh no tratamento de desordens associadas à deficiência de inibidor de c1 esterase
DK2407151T3 (da) Sammensætning til behandling af hud- og/eller neglelæsioner
EP3681962A4 (en) ACRYLIC MULSIONS MODIFIED WITH FUNCTIONAL (METH) ACRYLATES FOR CROSSLINKING
EA201792233A8 (ru) Способ уменьшения загрязнения поверхностей
BR112017006851A2 (pt) uso de ésteres de poliglicerol autoemulsificantes e hidrofóbicos como adjuvantes e agentes antidispersão por aspersão
BR112019024566A2 (pt) inibidores de pirazol magl
MA43270A (fr) Inhibiteur de la c1 estérase humaine recombinante et ses utilisations
BR112014020113A8 (pt) Composições farmacêuticas e método para diminuir a frequência de micção
MA40846A (fr) Compositions d'acides gras et d'esters d'acides gras auto-micellisantes, ainsi que leur utilisation dans le traitement d'états pathologiques
EP3581653A3 (en) Methods and compositions for treating cancer using peptide nucleic acid-based agents
BR112015013125A2 (pt) tratamento de lesões orais usando composições de matrix placentário extracelular
ECSP15003613A (es) Formulación transdérmica que contiene inhibidores de cox

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/12/2015, OBSERVADAS AS CONDICOES LEGAIS